SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-034444
Filing Date
2024-03-21
Accepted
2024-03-21 09:12:39
Documents
5
Effectiveness Date
2024-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 labp_s-8_3.21.24.htm S-8 108043
2 EX-5.1 labp-ex5_1.htm EX-5.1 19587
3 EX-23.1 labp-ex23_1.htm EX-23.1 3721
4 EX-FILING FEES labp-exfiling_fees.htm EX-FILING FEES 20332
5 GRAPHIC img155935805_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-24-034444.txt   193289
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278131 | Film No.: 24769707
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)